PL1888514T3 - Sole podstawionych estrów kwasu alofanowego i ich zastosowanie w środkach leczniczych - Google Patents

Sole podstawionych estrów kwasu alofanowego i ich zastosowanie w środkach leczniczych

Info

Publication number
PL1888514T3
PL1888514T3 PL06753677T PL06753677T PL1888514T3 PL 1888514 T3 PL1888514 T3 PL 1888514T3 PL 06753677 T PL06753677 T PL 06753677T PL 06753677 T PL06753677 T PL 06753677T PL 1888514 T3 PL1888514 T3 PL 1888514T3
Authority
PL
Poland
Prior art keywords
salts
drugs
allophanates
substituted
substituted allophanates
Prior art date
Application number
PL06753677T
Other languages
English (en)
Inventor
Robert Frank
Ruth Jostock
Hans Schick
Fritz Theil
Olga Gröger
Rene Kudick
Helmut Sonnenschein
Birgitta Henkel
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of PL1888514T3 publication Critical patent/PL1888514T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
    • C07C275/58—Y being a hetero atom
    • C07C275/60—Y being an oxygen atom, e.g. allophanic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL06753677T 2005-05-18 2006-05-17 Sole podstawionych estrów kwasu alofanowego i ich zastosowanie w środkach leczniczych PL1888514T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005023588A DE102005023588A1 (de) 2005-05-18 2005-05-18 Salze substituierter Allophansäureester und deren Verwendung in Arzneimitteln
EP06753677A EP1888514B1 (de) 2005-05-18 2006-05-17 Salze substituierter allophansäureester und deren verwendung in arzneimitteln
PCT/EP2006/004657 WO2006122772A1 (de) 2005-05-18 2006-05-17 Salze substituierter allophansäureester und deren verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
PL1888514T3 true PL1888514T3 (pl) 2009-08-31

Family

ID=37024738

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06753677T PL1888514T3 (pl) 2005-05-18 2006-05-17 Sole podstawionych estrów kwasu alofanowego i ich zastosowanie w środkach leczniczych

Country Status (7)

Country Link
US (1) US8173700B2 (pl)
EP (1) EP1888514B1 (pl)
AT (1) ATE425961T1 (pl)
DE (2) DE102005023588A1 (pl)
ES (1) ES2324492T3 (pl)
PL (1) PL1888514T3 (pl)
WO (1) WO2006122772A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3240B1 (ar) 2007-10-17 2018-03-08 Janssen Pharmaceutica Nv c-fms مثبطات كيناز
MX2010006504A (es) * 2007-12-12 2010-08-31 Archer Daniels Midland Co Conversion de carbohidratos a hidroxi-metilfurfural (hmf) y derivado.
EP2128226A1 (en) * 2008-05-19 2009-12-02 Furanix Technologies B.V Fuel component
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
JP2013518085A (ja) 2010-02-01 2013-05-20 ノバルティス アーゲー ＣＲＦ−１受容体アンタゴニストとしてのピラゾロ［５，１ｂ］オキサゾール誘導体
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
JP5748777B2 (ja) 2010-02-02 2015-07-15 ノバルティス アーゲー Ｃｒｆ受容体アンタゴニストとしてのシクロヘキシルアミド誘導体
EP2452652A1 (en) 2010-11-10 2012-05-16 Straumann Holding AG Non-invasive method for semi-automatic detection and measurement of periodontal bone defects
WO2013101977A1 (en) * 2011-12-30 2013-07-04 E. I. Du Pont De Nemours And Company Production of tetrahydrofuran-2, 5-dimethanol from isosorbide
US9670174B2 (en) * 2013-12-19 2017-06-06 Archer Daniels Midland Company Mono- and dialkyl ethers of furan-2,5-dimethanol and (tetra-hydrofuran-2,5-diyl)dimethanol and amphiphilic derivatives thereof
EP3401307A1 (en) * 2017-05-11 2018-11-14 Antalgenics, S.L. Trpv1 modulator compounds
CN111233797A (zh) * 2020-02-28 2020-06-05 浙江糖能科技有限公司 一种2,5-四氢呋喃二甲醇的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684728A (en) * 1979-01-12 1987-08-04 Bayer Aktiengesellschaft Solubilizing biologically active compounds with reactive hydrogen atoms
US5463011A (en) * 1993-06-28 1995-10-31 Zeneca Limited Acid derivatives
US20020019444A1 (en) * 2000-05-08 2002-02-14 Edward Hogestatt Anandamide and structurally related lipids as vanilloid receptor modulators
DE10131462A1 (de) * 2001-06-29 2003-01-09 Bayer Ag Phenol-Derivate

Also Published As

Publication number Publication date
DE502006003194D1 (de) 2009-04-30
EP1888514A1 (de) 2008-02-20
EP1888514B1 (de) 2009-03-18
US20090062383A1 (en) 2009-03-05
US8173700B2 (en) 2012-05-08
ATE425961T1 (de) 2009-04-15
WO2006122772A1 (de) 2006-11-23
ES2324492T3 (es) 2009-08-07
DE102005023588A1 (de) 2006-11-23

Similar Documents

Publication Publication Date Title
CY1110209T1 (el) Υποκατεστημενες ενωσεις βενζο(d)ισοξαζολ-3-υλ-αμινης σαν αναλγητικα
MX2009003382A (es) Derivados de sulfonamidas sustituidos.
WO2008046581A3 (de) Substituierte tetrahydropyrrolopyrazin-verbindungen als inhibitoren der monoaminwiederaufnahme und deren verwendung in arzeimitteln
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
PL1891004T3 (pl) Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych
MX2007003108A (es) Compuestos imidazo-3-il-amina sustituidos y biciclicos.
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
IL190654A (en) Methods of Methyl-Sulfonamido-Propanamido, Processes for Preparation and Medicines Containing Them
MX2007008790A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso.
TNSN08326A1 (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
EA201170753A1 (ru) Налмефена гидрохлорид дигидрат
MY149854A (en) Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
IL184314A0 (en) Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
WO2006018184A3 (de) Spirocyclische cyclohexan-derivate
UA94603C2 (ru) Производные тетрагидронафталина, способ их получения и их применения в качестве ингибиторов воспаления
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
PL1888514T3 (pl) Sole podstawionych estrów kwasu alofanowego i ich zastosowanie w środkach leczniczych
MX2007000224A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.
TW200639156A (en) New compounds
PL1758852T3 (pl) Podstawione związki cyklopentenu
MX2010002506A (es) Compuestos de nicotinamida sustituidos y uso de estos en medicamentos.
TW200619206A (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
MX2008011576A (es) Compuestos de imidazo[2,1-b]tiazol sustituidos y su uso para la produccion de farmacos.
MX2007006387A (es) Derivados de piridina 3-substituidos como antagonistas h3.